PR Newswire BiotechnologyCodex · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 08-24 20:42:00·⟳ 抓取 08-24 20:42:32 +32s·⚡ 决策 08-25 02:59:09 +6h16m·63.6 天前
Orthopedic Institute医生获Abbott神经调控SCS卓越中心医师认可
本次新闻是区域医生荣誉和渠道背书，不是上市公司收入、订单、审批、报销或指引事件；唯一直接可交易主体Abbott Laboratories（ABT.US）没有可量化增量。
📄 原文PR Newswire Biotechnology↗ 原文
James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician TEA…
不做 Abbott Laboratories（ABT.US）
不做Abbott Laboratories（ABT.US）：本事件只是医生荣誉/渠道背书，没有订单、审批、报销、收入指引或足以相对Abbott体量重估的新增事实。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Orthopedic Institute宣布James T. Brunz医生获Abbott Neuromodulation SCS卓越中心医师认可，说明其区域临床经验和KOL属性，但没有新增采购、装机、支付、适应症或财务指引。对Abbott Laboratories（ABT.US）而言，这只是品牌和临床教育层面的弱背景，且医生与Abbott/St. Jude关系长期存在，因此不构成可交易的预期差。
🔎 新鲜度:最早出现 2026-08-24 · 扩散 low · price-in 风险 low ↗
消息传播链
- Orthopedic Institute发布医生获Abbott Neuromodulation SCS卓越中心认可的新闻稿。
主要风险
- 若后续Abbott正式披露SCS产品重大订单、报销突破、适应症扩展或财务指引变化，需要重新评估。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-08-24 · 影响 weakens
可见事实均围绕医生荣誉、临床经验和产品背景，未发现新增采购、审批、报销或财务指引。
检索:Abbott Neuromodulation James Brunz SCS Center of Excellence order revenue approval reimbursement 原文 ↗
先例如何影响了这次决策
对本次决策的影响:确认不因新闻新鲜或出现Abbott名称而交易Abbott Laboratories（ABT.US）。
方向:没有可用于支持方向性交易的同市场同机制先例；医生荣誉认可类新闻缺少上市公司财务变量。
涨幅量级:无高相似先例可校准tp/sl。
形态:样本不足，但事件本身不是财务催化，先例不足不改变回避结论。
原文全文
展开原文 · 4,156 字
James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician
TEA, S.D., Aug. 24, 2026 /PRNewswire/ -- James T. Brunz, MD, an interventional spine and pain physician with Orthopedic Institute (OI), has been recognized by Abbott Neuromodulation as a Spinal Cord Stimulation (SCS) Center of Excellence physician based on his experience, clinical insights, and long-standing work with stimulation-based therapies for chronic pain.
According to Abbott Neuromodulation, Dr. Brunz is a strong proponent of spinal cord stimulation therapy and has served as a consultant on product design. He has performed more than 2,000 SCS implants throughout his career. Abbott has indicated that his experience places him among the top 5% of SCS implanters in the Upper Midwest and top 10% across the broader Midwest.
Spinal cord stimulation is an advanced neuromodulation therapy for select patients with chronic pain who have not achieved adequate relief through more conservative treatments. Dr. Brunz's neuromodulation practice includes spinal cord stimulation and dorsal root ganglion (DRG) stimulation, with an emphasis on careful patient selection and appropriate therapy matching.
"Dr. Brunz has demonstrated significant experience and clinical insight in spinal cord stimulation and neuromodulation therapy," said Todd Woodson, Area Vice President, Abbott Neuromodulation. "Based on his experience, procedural history, and contributions as a clinical resource, Abbott Neuromodulation recognizes Dr. Brunz as a Spinal Cord Stimulation Center of Excellence physician."
"I have worked directly with Dr. Brunz in the operating room and have seen firsthand his experience, consistency, and understanding of spinal cord stimulation therapy," said Scott Mattecheck, Territory Manager, Abbott Neuromodulation. "He has been a valuable clinical resource in the region for patients with complex chronic pain."
"Spinal cord stimulation is not appropriate for every patient, but for carefully selected individuals with chronic pain that has not responded to other treatments, it can be an important therapy to consider," said Dr. Brunz. "My focus is identifying the source of a patient's pain and matching the right treatment to the right patient."
A fellowship-trained interventional spine physician with more than 20 years of experience, Dr. Brunz treats complex spine and pain conditions at Orthopedic Institute, collaborating with orthopedic surgeons, rehabilitation specialists, and advanced practice providers.
In addition to his Abbott designation, Dr. Brunz is a listed Intracept Center of Excellence physician for vertebrogenic low back pain. He is the only physician in South Dakota recognized with both the Abbott Neuromodulation Spinal Cord Stimulation Center of Excellence and Intracept Center of Excellence distinctions.
Patients considered for SCS may include those with chronic pain that has not improved adequately with conservative care or previous treatment. Candidates typically complete a temporary stimulation trial before permanent implantation to determine whether the therapy provides meaningful relief.
About Dr. James T. Brunz
James T. Brunz, MD, is a fellowship-trained interventional spine and pain physician at Orthopedic Institute specializing in complex spine and pain conditions. His clinical focus includes vertebrogenic low back pain, basivertebral nerve ablation, spinal cord stimulation, dorsal root ganglion stimulation, and advanced interventional pain care. He has served as a regional clinical resource and key opinion leader in neuromodulation since being recognized by St. Jude Medical/Abbott in 2013.
About Orthopedic Institute
Founded in 1972, Orthopedic Institute (OI) is an independent physician group specializing in orthopedics, sports medicine, and interventional spine and pain care. With 21 physicians and more than 225 employees, OI serves patients across South Dakota, Minnesota, and Iowa from its main clinic in Tea, South Dakota, and regional locations. www.orthopedicinstitutesf.com
Media Contact:
Helen Kluck
[email protected]
605.331.5890
SOURCE Orthopedic Institute
TEA, S.D., Aug. 24, 2026 /PRNewswire/ -- James T. Brunz, MD, an interventional spine and pain physician with Orthopedic Institute (OI), has been recognized by Abbott Neuromodulation as a Spinal Cord Stimulation (SCS) Center of Excellence physician based on his experience, clinical insights, and long-standing work with stimulation-based therapies for chronic pain.
According to Abbott Neuromodulation, Dr. Brunz is a strong proponent of spinal cord stimulation therapy and has served as a consultant on product design. He has performed more than 2,000 SCS implants throughout his career. Abbott has indicated that his experience places him among the top 5% of SCS implanters in the Upper Midwest and top 10% across the broader Midwest.
Spinal cord stimulation is an advanced neuromodulation therapy for select patients with chronic pain who have not achieved adequate relief through more conservative treatments. Dr. Brunz's neuromodulation practice includes spinal cord stimulation and dorsal root ganglion (DRG) stimulation, with an emphasis on careful patient selection and appropriate therapy matching.
"Dr. Brunz has demonstrated significant experience and clinical insight in spinal cord stimulation and neuromodulation therapy," said Todd Woodson, Area Vice President, Abbott Neuromodulation. "Based on his experience, procedural history, and contributions as a clinical resource, Abbott Neuromodulation recognizes Dr. Brunz as a Spinal Cord Stimulation Center of Excellence physician."
"I have worked directly with Dr. Brunz in the operating room and have seen firsthand his experience, consistency, and understanding of spinal cord stimulation therapy," said Scott Mattecheck, Territory Manager, Abbott Neuromodulation. "He has been a valuable clinical resource in the region for patients with complex chronic pain."
"Spinal cord stimulation is not appropriate for every patient, but for carefully selected individuals with chronic pain that has not responded to other treatments, it can be an important therapy to consider," said Dr. Brunz. "My focus is identifying the source of a patient's pain and matching the right treatment to the right patient."
A fellowship-trained interventional spine physician with more than 20 years of experience, Dr. Brunz treats complex spine and pain conditions at Orthopedic Institute, collaborating with orthopedic surgeons, rehabilitation specialists, and advanced practice providers.
In addition to his Abbott designation, Dr. Brunz is a listed Intracept Center of Excellence physician for vertebrogenic low back pain. He is the only physician in South Dakota recognized with both the Abbott Neuromodulation Spinal Cord Stimulation Center of Excellence and Intracept Center of Excellence distinctions.
Patients considered for SCS may include those with chronic pain that has not improved adequately with conservative care or previous treatment. Candidates typically complete a temporary stimulation trial before permanent implantation to determine whether the therapy provides meaningful relief.
About Dr. James T. Brunz
James T. Brunz, MD, is a fellowship-trained interventional spine and pain physician at Orthopedic Institute specializing in complex spine and pain conditions. His clinical focus includes vertebrogenic low back pain, basivertebral nerve ablation, spinal cord stimulation, dorsal root ganglion stimulation, and advanced interventional pain care. He has served as a regional clinical resource and key opinion leader in neuromodulation since being recognized by St. Jude Medical/Abbott in 2013.
About Orthopedic Institute
Founded in 1972, Orthopedic Institute (OI) is an independent physician group specializing in orthopedics, sports medicine, and interventional spine and pain care. With 21 physicians and more than 225 employees, OI serves patients across South Dakota, Minnesota, and Iowa from its main clinic in Tea, South Dakota, and regional locations. www.orthopedicinstitutesf.com
Media Contact:
Helen Kluck
[email protected]
605.331.5890
SOURCE Orthopedic Institute
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。